Skip to main content
Clinical Trials/NCT06128785
NCT06128785
Not yet recruiting
Not Applicable

Electroacupuncture Promotes Gastrointestinal Functional Recovery After Radical Colorectal Cancer Surgery: a Multicenter Randomized Controlled Study

Shanghai Yueyang Integrated Medicine Hospital1 site in 1 country300 target enrollmentNovember 6, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Shanghai Yueyang Integrated Medicine Hospital
Enrollment
300
Locations
1
Primary Endpoint
Time of first postoperative exhaust
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to verify the efficacy of electroacupuncture in accelerating the recovery of gastrointestinal function after colorectal cancer surgery. The main questions it aims to answer are:

  • Whether electroacupuncture can accelerate the recovery of gastrointestinal function in patients after colorectal cancer surgery.
  • Whether electroacupuncture intervention is safe for postoperative colorectal cancer patients.

Participants will be randomized into 3 groups:

The conventional control group will receive postoperative rehydration and nutritional support, correction of acid-base imbalance and electrolyte disturbance, anti-infection, hemostasis and other symptomatic treatments.

In the electroacupuncture group, acupuncture will be performed within 6 hours after surgery on the basis of the conventional control group. Acupoint: bilateral Hegu (LI4), Zhigou (SJ6), Zusanli (ST36), Shangjuxu (ST37). Both after obtaining Qi, and unilaterally connected to the electroacupuncture instrument for electrical stimulation, the current frequency is continuous wave 5 Hz, the intensity of stimulation was as the patient tolerated, each time lasting 30 min. Acupuncture stimulation was given every 12 h. The course of treatment was terminated postoperatively until the fourth postoperative day (d0-d4) or until the patient showed the first postoperative anal exhaust or continued until the fourth day.

The sham acupuncture group will based on the conventional control group, using a blunt-tipped needle tip that do not pierce the adhesive pad.

Detailed Description

Colorectal cancer is the most common and predominant malignancy, and radical resection surgery, as the main method of current treatment for colon and gastrointestinal cancers, is performed on a large number of patients each year. Clinically, abdominal surgery causes the highest frequency of gastrointestinal dysfunction and the longest relative duration of dysfunction. A condition in which gastrointestinal function has not fully recovered after abdominal surgery is called gastrointestinal dysfunction. The common symptoms of postoperative gastrointestinal dysmotility are abdominal distension, abdominal pain, nausea and vomiting, diminished or even absent bowel sounds, loss of anal discharge, loss of bowel movements, and even secondary symptoms such as fever and pulmonary infection. It will adversely affect patients' postoperative quality of life to varying degrees, weaken their gastrointestinal barrier capacity, and severe gastrointestinal dysfunction can lead to complications such as electrolyte disorders, intestinal adhesions, intestinal obstruction, anastomotic fistula, and abdominal wall incision dehiscence in patients, as well as increase the social burden and the economic burden of patients. Some clinical reports show that acupuncture has good efficacy on gastrointestinal dysfunction, and acupuncture has effects on the gastrointestinal tract such as promoting gastrointestinal motility and reducing the inflammatory response of the gastrointestinal tract. In this study, a multicenter, randomized, blinded, sham acupuncture-controlled clinical design will be used to verify the efficacy of postoperative electroacupuncture in accelerating the recovery of gastrointestinal function after colorectal cancer surgery. Participants will be randomized into 3 groups: The conventional control group will receive postoperative rehydration and nutritional support, correction of acid-base imbalance and electrolyte disturbance, anti-infection, hemostasis and other symptomatic treatments. In the electroacupuncture group, acupuncture will be performed within 6 hours after surgery on the basis of the conventional control group. Acupoint: bilateral Hegu (LI4), Zhigou (SJ6), Zusanli (ST36), Shangjuxu (ST37). Both after obtaining Qi, and unilaterally connected to the electroacupuncture instrument for electrical stimulation, the current frequency is continuous wave 5 Hz, the intensity of stimulation was as the patient tolerated, each time lasting 30 min. Acupuncture stimulation was given every 12 h. The course of treatment was terminated postoperatively until the fourth postoperative day (d0-d4) or until the patient showed the first postoperative anal exhaust or continued until the fourth day. The sham acupuncture group will based on the conventional control group, using a blunt-tipped needle tip that do not pierce the adhesive pad. In other words, the electroacupuncture instrument show the state of being connected, but it is not actually energized; the acupuncture points, acupuncture time points, frequency, retention time and treatment duration were the same as those of the intervention group.

Registry
clinicaltrials.gov
Start Date
November 6, 2023
End Date
January 30, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Shanghai Yueyang Integrated Medicine Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Surgical patients who meet the diagnostic criteria for colorectal cancer and require elective radical colorectal cancer surgery;
  • 18 years old ≤ age ≤ 79 years old, with no restriction on gender;
  • Understand, agree to participate in this study and sign the informed consent form;
  • American society of Aneshesiologists (ASA) classification I to III.

Exclusion Criteria

  • Patients with psychiatric disorders;
  • Patients who have participated or are participating in other clinical studies in the 3 months prior to enrollment;
  • Patients with severe malnutrition (NRS2002 score ≥ 3);
  • Patients with total colectomy;
  • Patients undergoing ileal diversion for rectal cancer;
  • Patients with tumor infiltration requiring resection of other organs;
  • Prophylactic fistulae.
  • Anyone who meets any of the above criteria will be excluded from the study.

Outcomes

Primary Outcomes

Time of first postoperative exhaust

Time Frame: up to 4 days after surgery.

The time between the patient's first exhaust and the end of surgery will be recorded.

Secondary Outcomes

  • Number of Postoperative nausea and vomiting episods(up to 4 days after surgery.)
  • Quality of life scale 1(baseline, discharge 1 day, 1 month after surgery.)
  • Biochemical indexes 1(1 hour postoperatively, 12 hours postoperatively, 72 hours postoperatively.)
  • Biochemical indexes 2(1 hour postoperatively, 12 hours postoperatively, 72 hours postoperatively.)
  • Biochemical indexes 3(baseline, discharge 1 day.)
  • Length of recovery of bowel sounds after surgery ( Yueyang Hospital records only)(up to 4 days after surgery.)
  • Quality of life scale 2(baseline, discharge 1 day, 1 month after surgery.)
  • Postoperative hospitalization days(up to 4 days)
  • Visual Analog Scale (VAS) of Pain(up to 4 days after surgery.)
  • Time of first postoperative defecation(up to 4 days after surgery.)
  • Time of first postoperative intake of water(up to 4 days after surgery.)

Study Sites (1)

Loading locations...

Similar Trials